GEN’s Editor-in-Chief John Sterling talks with John Quackenbush, Ph.D., from the Dana-Farber Cancer Institute.

Previous articleMultibillion-Dollar Depression Market Gets Crowded
Next articleSRI to Develop Telik’s Autoimmune and Inflammatory Disease Candidate